» Articles » PMID: 26700799

The Effect of Olive Oil-based Ketogenic Diet on Serum Lipid Levels in Epileptic Children

Overview
Journal Neurol Sci
Specialty Neurology
Date 2015 Dec 25
PMID 26700799
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ketogenic diet (KD) is one of the most effective therapies for intractable epilepsy. Olive oil is rich in monounsaturated fatty acids and antioxidant molecules and has some beneficial effects on lipid profile, inflammation and oxidant status. The aim of this study was to evaluate the serum lipid levels of children who were receiving olive oil-based KD for intractable seizures at least 1 year. 121 patients (mean age 7.45 ± 4.21 years, 57 girls) were enrolled. At baseline and post-treatment 1, 3, 6, and 12 months body mass index-SDS, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride levels were measured. Repeated measure ANOVA with post hoc Bonferroni correction was used for data analysis. The mean duration of KD was 15.4 ± 4.1 months. Mean total cholesterol, LDL-cholesterol and triglyceride levels were significantly higher at 1st, 3rd, 6th and 12th months of the KD treatment, compared to pre-treatment levels (p = 0.001), but showed no difference among during-treatment measurements. Mean body mass index-SDS and HDL-cholesterol levels were not different among the baseline and follow-up time points (p = 0.113 and p = 0.067, respectively). No child in this study discontinued the KD because of dyslipidemia. Even if rich in olive oil, high-fat KD causes significant increase in LDL-cholesterol and triglyceride levels. More studies are needed to determine the effect of KD on serum lipids in children using different fat sources in the diet.

Citing Articles

Ketogenic therapy in childhood and adolescence: recommendations of the Brazilian experts group.

Sampaio L, Maria de Miranda Henriques-Souza A, Lin K, Lopes Neri L, Inuzuka L, Uchoa L Arq Neuropsiquiatr. 2023; 81(6):597-606.

PMID: 37379871 PMC: 10658610. DOI: 10.1055/s-0043-1768676.


A Review of Ketogenic Dietary Therapies for Epilepsy and Neurological Diseases: A Proposal to Implement an Adapted Model to Include Healthy Mediterranean Products.

Ferraris C, Guglielmetti M, Lopes Neri L, Allehdan S, Mohsin Albasara J, Fareed Alawadhi H Foods. 2023; 12(9).

PMID: 37174282 PMC: 10178865. DOI: 10.3390/foods12091743.


Impact of two ketogenic diet types in refractory childhood epilepsy.

El-Shafie A, Bahbah W, Abd El Naby S, Omar Z, Basma E, Hegazy A Pediatr Res. 2023; 94(6):1978-1989.

PMID: 36906721 PMC: 10007663. DOI: 10.1038/s41390-023-02554-w.


Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned.

Zarnowska I Nutrients. 2020; 12(9).

PMID: 32867258 PMC: 7551948. DOI: 10.3390/nu12092616.


Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?.

Morris G, Puri B, Carvalho A, Maes M, Berk M, Ruusunen A Int J Neuropsychopharmacol. 2020; 23(6):366-384.

PMID: 32034911 PMC: 7311648. DOI: 10.1093/ijnp/pyaa008.


References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Verrotti A, Basciani F, Domizio S, Sabatino G, Morgese G, Chiarelli F . Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol. 1999; 19(5):364-7. DOI: 10.1016/s0887-8994(98)00084-8. View

3.
Venturini D, Simao A, Urbano M, Dichi I . Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome. Nutrition. 2015; 31(6):834-40. DOI: 10.1016/j.nut.2014.12.016. View

4.
Groesbeck D, Bluml R, Kossoff E . Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006; 48(12):978-81. DOI: 10.1017/S0012162206002143. View

5.
Sonmez F, Demir E, Orem A, Yildirmis S, Orhan F, Aslan A . Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. J Child Neurol. 2006; 21(1):70-4. DOI: 10.1177/08830738060210011301. View